Literature DB >> 18544249

The application of fast multiparametric protocol MRI-based thrombolysis with rt-PA hyperacute cerebral infarction.

Qingke Bai1, Zhenguo Zhao, Yuehua Li, Haijing Sui, Xiuhai Xie, Yi Gong, Xiaohui Zhao, Lianwen Wang, Weiying Xia, Jian Shen, Lianjun Lu.   

Abstract

OBJECTIVE: To investigate the value of fast multiparametric protocol magnetic resonance imaging (MRI)-based thrombolysis in hyperacute cerebral infarction.
METHODS: Seventy-seven patients with acute ischemic stroke were examined by multiparametric protocol MRI and among them, 12 patients with hyperacute cerebral infarction were treated by recombinant tissue plasminogen activator (rt-PA) and followed up periodically by MRI.
RESULTS: The 12 patients selected by FMPMRI to receive thrombolysis demonstrated clinical improvement, with 90 day modified Rankin scale scores (mRs) < or = 2 and life quality Barthel index (BI) of 80-100. The only complication involved one patient (8.3%) who developed an asymptomatic intracranial hemorrhage 3 weeks after receiving thrombolytics.
CONCLUSION: Multiparametric protocols have significant clinical potential for the treatment of hyperacute stroke patients who are candidates for receiving intravenous thrombolytic therapy. Our data suggest that patients suffering from hyperacute ischemic cerebral infarction that are strong candidates for intravenous thrombolytic therapy can be identified by multiparametric protocol MRI, especially to those whose time windows were undefined or beyond 3 hours after symptom onset.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544249     DOI: 10.1179/174313208X300314

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  6 in total

1.  Magnetic resonance diffusion-perfusion mismatch in acute ischemic stroke: An update.

Authors:  Feng Chen; Yi-Cheng Ni
Journal:  World J Radiol       Date:  2012-03-28

2.  Value of MRI in medicine: More than just another test?

Authors:  Edwin J R van Beek; Christiane Kuhl; Yoshimi Anzai; Patricia Desmond; Richard L Ehman; Qiyong Gong; Garry Gold; Vikas Gulani; Margaret Hall-Craggs; Tim Leiner; C C Tschoyoson Lim; James G Pipe; Scott Reeder; Caroline Reinhold; Marion Smits; Daniel K Sodickson; Clare Tempany; H Alberto Vargas; Meiyun Wang
Journal:  J Magn Reson Imaging       Date:  2018-08-25       Impact factor: 4.813

3.  Prognostic Value of Diffusion-Weighted Imaging (DWI) Apparent Diffusion Coefficient (ADC) in Patients with Hyperacute Cerebral Infarction Receiving rt-PA Intravenous Thrombolytic Therapy.

Authors:  Hai-Jing Sui; Cheng-Gong Yan; Zhen-Guo Zhao; Qing-Ke Bai
Journal:  Med Sci Monit       Date:  2016-11-19

4.  Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.

Authors:  Qing-Ke Bai; Zhen-Guo Zhao; Lian-Jun Lu; Jian Shen; Jian-Ying Zhang; Hai-Jing Sui; Xiu-Hai Xie; Juan Chen; Juan Yang; Cui-Rong Chen
Journal:  Stroke Vasc Neurol       Date:  2019-02-11

5.  Clinical comparison of intravenous thrombolysis and bridging artery thrombectomy in hyperacute ischemic stroke with unknown time of onset.

Authors:  Bai Qingke; Zheng Ping; Zhang Jianying; Zhao Zhenguo
Journal:  Arch Med Sci       Date:  2021-11-09       Impact factor: 3.318

6.  MRI-guided thrombolysis for lenticulostriate artery stroke within 12 h of symptom onset.

Authors:  Jianying Zhang; Qingke Bai; Zhenguo Zhao; Yiting Mao; Qiang Dong; Wenjie Cao
Journal:  Sci Rep       Date:  2022-05-06       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.